Lantheus to Present at the Wells Fargo Healthcare Conference
September 1, 2022
NORTH BILLERICA, Mass., Sept. 01, 2022 (GLOBE NEWSWIRE) --Lantheus Holdings, Inc.("the Company") (NASDAQ: LNTH), an established leader and fully integrated provider committed to innovative diagnostics, targeted therapeutics and artificial intelligence solutions that empower clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced Bob Marshall, Chief Financial Officer and Treasurer, and Paul Blanchfield, Chief Operating Officer, will present at the Wells Fargo Healthcare Conference at 8:00 a.m. ET on Thursday, September 8.
To access a live webcast of the presentation, please visit the Investorssection of the Company's website at www.lantheus.com. A replay of the webcast will be available on the Company's website for at least 30 days following the live presentation.
About Lantheus
With more than 60 years of experience in delivering life-changing science, Lantheus is committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease. Lantheus is headquartered in Massachusetts and has offices in New Jersey, Canada and Sweden. For more information, visit www.lantheus.com.
Contacts:
Mark Kinarney
Vice President, Investor Relations 978-671-8842ir@lantheus.com
Melissa Downs
Senior Director, Corporate Communications 646-975-2533
Source: Lantheus Holdings, Inc.
Attachments
Disclaimer
Lantheus Holdings Inc. published this content on 01 September 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 September 2022 12:43:10 UTC.